Your browser doesn't support javascript.
loading
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.
Xu, Heng; Robinson, Giles W; Huang, Jie; Lim, Joshua Yew-Suang; Zhang, Hui; Bass, Johnnie K; Broniscer, Alberto; Chintagumpala, Murali; Bartels, Ute; Gururangan, Sri; Hassall, Tim; Fisher, Michael; Cohn, Richard; Yamashita, Tetsuji; Teitz, Tal; Zuo, Jian; Onar-Thomas, Arzu; Gajjar, Amar; Stewart, Clinton F; Yang, Jun J.
Afiliação
  • Xu H; 1] Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. [2] Department of Laboratory Medicine, National Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Ch
  • Robinson GW; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Huang J; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Lim JY; 1] Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. [2] Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Zhang H; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Bass JK; Rehabilitation Services, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Broniscer A; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Chintagumpala M; Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
  • Bartels U; Department of Haematology and Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Gururangan S; Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA.
  • Hassall T; Department of Oncology, The Royal Children's Hospital, Parkville, Victoria, Australia.
  • Fisher M; Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Cohn R; School of Women's and Children's Health, University of New South Wales, Kensington, New South Wales, Australia.
  • Yamashita T; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Teitz T; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Zuo J; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Onar-Thomas A; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Gajjar A; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Stewart CF; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Yang JJ; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Nat Genet ; 47(3): 263-6, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25665007
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cisplatino / Hidrolases Anidrido Ácido / Perda Auditiva / Antineoplásicos Limite: Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cisplatino / Hidrolases Anidrido Ácido / Perda Auditiva / Antineoplásicos Limite: Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article